Related Experiment Video
Updated: May 28, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Potential utility of postmortem CT-based classification as a practical pre-autopsy assessment tool for hepatic
Ji-Hwan Park1, Ji Su Han2, Hyeong-Geon Kim3
1Department of Forensic Medicine, National Forensic Service Seoul Institute, Seoul, 08063, Republic of Korea. hbpjh1206@korea.kr.
None:
This study aimed to establish postmortem computed tomography (PMCT)-specific Hounsfield unit (HU) criteria and developed an HU-based assessment tool for pre-autopsy triage of hepatic steatosis. Overall, 166 deceased individuals underwent whole-body PMCT followed by autopsy with liver histopathology. Hepatic attenuation was measured as a volumetric mean HU of the entire liver and as a four-point mean HU. No significant difference was noted between the volumetric and four-point mean HU (p = 0.183). However, the four-point mean HU differed significantly across histological steatosis grades (p < 0.001) and decreased with increasing severity, although the difference between mild and moderate steatosis was non-significant (p = 0.981). Receiver operating characteristic analysis indicated an optimal cutoff of 42.59 HU (sensitivity 60.7%, specificity 86.1%), from which three HU-based categories were defined (≥ 44.5 HU: normal; 42.0-44.4 HU: borderline; <42.0 HU: suspected steatosis). In the validation cohort (n = 104), the tool achieved an accuracy of 0.865, sensitivity of 0.756, specificity of 0.949, precision of 0.919, and F1-score of 0.829. This three-category PMCT HU-based classification system provides a practical tool for the triage of hepatic steatosis. The high specificity and precision support its use as a rule-in aid to prioritize suspected steatosis cases and improve autopsy workflow efficiency.
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
